[The influence of cefpirome on intestinal bacterial flora]. 1991

S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
Department of Pediatrics, Kasumigaura National Hospital.

Cefpirome (CPR, HR810), a new parenteral cephalosporin antibiotic, was studied for its effect on the intestinal bacterial flora in pediatric patients. The subjects were children admitted for infections (6 males and 3 females, 1 month to 5 years 1 month old, weighted 3.94 to 21.0 kg). CPR was intravenously administered at a dose between 19.0 to 40.0 mg/kg, 3 to 4 doses daily over 6 to 12 days. The feces from these children were collected before, during, and after administration, and bacteria were identified and counted. CPR concentration, beta-lactamase activity, and Clostridium difficile D-1 antigen were also assayed. Bacterial flora changes in feces during CPR administration showed some variance, but generally 5 cases out of the 9 showed a significant decrease in Enterobacteriaceae and Enterococcus faecalis among aerobic bacteria. The other 4 cases showed some transient decrease, but no significant change was observed. No significant changes were recognized for Enterococcus avium and Enterococcus faecium, and the total aerobic bacterial count decreased in a transient manner in only one patient. Regarding anaerobic bacteria, Bifidobacterium and Eubactrium revealed a significant decrease, a transient decrease or no change from case to case. Bacteroides showed little change in count. Consequently, the total anaerobic bacteria count did not reveal a large change aside from 1 case in which Bacteroides was not detected before administration and a significant decrease of other bacteria was noted. In no case, glucose nonfermentative Gram-negative bacilli or fungi were found dominant. Although C. difficile and C. difficile D-1 antigen were detected in 3 and 4 cases, respectively, there was no exact relationship between the number of C. difficile and the characteristics of the feces. CPR was detected in fecal samples from 6 cases during administration with concentrations ranging between 1.20 to 22.4 micrograms/g. High values of CPR tended to be found in specimens with low beta-lactamase activity in the feces. When drug sensitivities of the bacteria isolated from feces before and after administration were compared, higher levels of resistance were found in some bacteria such as Enterococci and Bacteroides during or after administration than before administration. The above results suggest that CPR is a drug with a relatively small influence on the intestinal bacterial flora in children, but a particular attention is required for diarrhea and microbial replacement during a continuous, long-term administration of the drug.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008297 Male Males
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females

Related Publications

S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
April 1991, The Japanese journal of antibiotics,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
December 1988, The Japanese journal of antibiotics,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
December 1993, The Japanese journal of antibiotics,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
July 1989, The Japanese journal of antibiotics,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
August 1989, The Japanese journal of antibiotics,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
December 1966, Proceedings of the Royal Society of Medicine,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
August 1986, The Japanese journal of antibiotics,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
April 1968, Minerva pediatrica,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
April 1961, Gaceta medica de Mexico,
S Iwata, and M Ikeda, and E Isohata, and Y Kin, and T Yokota, and Y Kusumoto, and Y Sato, and H Akita, and T Oikawa, and K Sunakawa
April 1992, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!